Cited by 441MicroRNA in disease regulationCancer-related molecular mechanisms researchLung Cancer Research Studies

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR

Open access

Markou, Athina, Tsaroucha, Emily G, Kaklamanis, Loukas, Fotinou, Marianthi, Georgoulias, Vassilis, Lianidou, Evi S·2008·Clinical Chemistry

DOI 10.1373/clinchem.2007.101741

Open this paper in CoChat — free account Open PDF

Abstract

Background: microRNA (miRNA) expression profiles are being intensively investigated for their involvement in carcinogenesis. We evaluated the prognostic value of mature microRNA-21 (miR-21) and mature microRNA-205 (miR-205) overexpression in non–small cell lung cancer (NSCLC). Patients and methods: We studied 48 pairs of NSCLC fresh frozen tissue specimens collected at time of surgery and before chemotherapy. Highly specific amplification and quantification of mature miR-21 and mature miR-205 was achieved using looped real time RT-PCR. Results: miRNA expression, determined by real time RT-PCR, was defined by ΔΔCt measurements. We detected overexpression of mature miR-21 in 25 (52.0%) of the 48 NSCLC paired specimens and overexpression of miR-205 in 31 (64.6%). Overexpression was assessed after comparison of miRNA expression in NSCLC tissues and in their corresponding noncancerous tissues with respect to U6 expression. During the follow-up period, 29 of 48 (60.4%) patients relapsed, and 23 of 48 died (47.9%). Mature miR-21 was upregulated in 16 of 29 (55.2%) patients who relapsed and 15 of 23 (65.2%) patients who died. Mature miR-205 was overexpressed in 19 of 29 patients who relapsed (65.5%) and 15 of 23 patients who died (65.2%). Mature miR-21 overexpression correlated with overall survival (OS) of the patients (P = 0.027), whereas overexpression of mature miR-205 did not. Conclusions: Our results suggest that overexpression of mature miR-21 is an independent negative prognostic factor for OS in NSCLC patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1373/clinchem.2007.101741

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053

Show all 39 references

Research works printed but not linked: 1

2006, Mol Vis, 12, 1175

Sorted by citations

Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
MicroRNA: Biogenesis, Function and Role in Cancer
MacFarlane, L.-A., & R. Murphy, P. (2010) · Current Genomics · doi:10.2174/138920210793175895 · Cited by 1,584
Cancer biomarker detection: recent achievements and challenges
Wu, L. J., & Qu, X. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00370e · Cited by 1,252
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Iorio, M. V., & Croce, C. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.0317 · Cited by 973
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., Calabrò, E., Croce, C. M., Pastorino, U., & Sozzi, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100048108 · Cited by 722
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 671
MicroRNAs and complex diseases: from experimental results to computational models
Chen, X., Xie, D., Zhao, Q., & You, Z. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx130 · Cited by 641
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626
“Recently, miR-21 expression levels have proven useful prognostic markers in NSCLC (Markou et al., 2008; Yanaihara et al., 2006).”
MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)
Zhang, J.-G., Wang, J., Zhao, F., Liu, Q., Jiang, K., & Yang, G. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.02.074 · Cited by 574
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
Xu, J., Wu, C., Che, X., Wang, L., Yu, D., Zhang, T., Huang, L., Li, H., Tan, W., Wang, C., et al. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20712 · Cited by 567
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Zen, K., & Zhang, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20215 · Cited by 509
RWRMDA: predicting novel human microRNA–disease associations
Chen, X., Liu, M.-X., & Yan, G. (2012) · Molecular BioSystems · doi:10.1039/c2mb25180a · Cited by 433
Prioritization of disease microRNAs through a human phenome-microRNAome network
Jiang, Q., Hao, Y., Wang, G., Juan, L., Zhang, T., Teng, M., Liu, Y., & Wang, Y. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-s1-s2 · Cited by 392
Semi-supervised learning for potential human microRNA-disease associations inference
Chen, X., & Yan, G. (2014) · Scientific Reports · doi:10.1038/srep05501 · Cited by 378
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
Liu, X., Sempere, L. F., Ouyang, H., Memoli, V. A., Andrew, A. S., Luo, Y. Y., Demidenko, E., Korc, M., Shi, W., Preis, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39566 · Cited by 377
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
Allegra, A., Alonci, A., Campo, S., Penna, G., Petrungaro, A., Gerace, D. G., & Musolino, C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1647 · Cited by 363
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Gallardo, E., Navarro, A., Viñolas, N., Marrades, R. M., Díaz, T., Gel, B., Quera, A., Bandrés, E., García‐Foncillas, J., Ramirez, J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp219 · Cited by 346
MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN
Liu, Z., Wang, H., Liu, J., & Wang, Z.-X. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1443-3 · Cited by 323
MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
Landi, M. T., Zhao, Y., Rotunno, M., Koshiol, J. E., Liu, H., Bergen, A. W., Rubagotti, M., Goldstein, A. M., Linnoila, I. R., Marincola, F. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1736 · Cited by 323
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer
Xie, Y., Todd, N. W., Liu, Z., Zhan, M., Fang, H., Peng, H., Alattar, M., Deepak, J., Stass, S. A., & Jiang, F. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.04.004 · Cited by 316
The role of microRNAs in colorectal cancer
Schetter, A. J., Okayama, H., & Harris, C. C. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b78f · Cited by 252
Novel classes of non-coding RNAs and cancer
Šáňa, J., Vychytilova‐Faltejskova, P., Svoboda, M., & Slabý, O. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-103 · Cited by 314
Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
Qi, P., Cheng, S., Wang, H., Li, N., Chen, Y., & Gao, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028486 · Cited by 288
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
Gee, H. E., Buffa, F. M., Camps, C., Ramachandran, A., Leek, R., Taylor, M., Patil, M., Sheldon, H., Betts, G. N. J., Homer, J. J., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606076 · Cited by 285
Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers
Cui, L., Lou, Y., Zhang, X., Zhou, H., Deng, H., Song, H., Yu, X., Xiao, B., Wang, W., & Guo, J. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.06.004 · Cited by 284
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
Nielsen, B. S., Jørgensen, S., Fog, J. U., Søkilde, R., Christensen, I. J., Hansen, U., Brünner, N., Baker, A., Møller, S., & Nielsen, H. J. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9355-7 · Cited by 279
MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma
Hiyoshi, Y., Kamohara, H., Karashima, R., Sato, N., Imamura, Y., Nagai, Y., Yoshida, N., Toyama, E., Hayashi, N., Watanabe, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2545 · Cited by 269
Micromarkers: miRNAs in cancer diagnosis and prognosis
Ferracin, M., Veronese, A., & Negrini, M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.11 · Cited by 269
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
Qian, B., Katsaros, D., Lu, L., Preti, M., Durando, A., Arisio, R., Mu, L., & Yu, H. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0219-7 · Cited by 269
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., Lambert, V., Gonzalez, M.-L. A., Colige, A., Rakic, J., Noël, A., MARTIAL, J. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016979 · Cited by 257
hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
Gee, H. E., Camps, C., Buffa, F. M., Patiar, S., Winter, S. C., Betts, G. N. J., Homer, J. J., Corbridge, R., Cox, G. J., West, C., et al. (2010) · Cancer · doi:10.1002/cncr.25009 · Cited by 252
High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer
Liu, X., Zhu, W., Huang, Y., Ma, L., Zhou, S., Wang, Y., Fang, Z., Zhou, J., & Zhang, Y. (2011) · Medical Oncology · doi:10.1007/s12032-011-9923-y · Cited by 246
Molecular Biology of Lung Cancer: Clinical Implications
Larsen, J. E., & Minna, J. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.003 · Cited by 251
Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection
Li, B., Zhao, Y., Guo, G., Li, W., Zhu, E., Luo, X. L., Mao, X., Zou, Q., Yu, P.-W., Zuo, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041629 · Cited by 242
Predicting human microRNA-disease associations based on support vector machine
Jiang, Q., Wang, G., Jin, S., Li, Y., & Wang, Y. (2013) · International Journal of Data Mining and Bioinformatics · doi:10.1504/ijdmb.2013.056078 · Cited by 236
Overview upon miR-21 in lung cancer: focus on NSCLC
Bica, C., Cojocneanu, R., Magdo, L., Ráduly, L., Gulei, D., & Berindan‐Neagoe, I. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2877-x · Cited by 235
Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls
Witten, D., Tibshirani, R. J., Gu, S. G., Fire, A. Z., & Lui, W. (2010) · BMC Biology · doi:10.1186/1741-7007-8-58 · Cited by 234
Biomarkers for Colorectal Cancer
Tanaka, T., Tanaka, T., Tanaka, M., & Ishigamori, R. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11093209 · Cited by 230
High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer
Yang, M., Shen, H., Qiu, C., Yang, N., Wang, L., Dong, W., Liao, Y., & Du, J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.031 · Cited by 226
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation
Cho, W. C. S., Chow, A. S. C., & Au, J. S. K. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.039 · Cited by 225
Quantification of Circulating miRNAs in Plasma
Sourvinou, I. S., Markou, A. N., & Lianidou, E. S. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.07.005 · Cited by 219
Self-citation
Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells
Jiang, L., Huang, Q. M., Zhang, S., Zhang, Q., Chang, J., Qiu, X., & Wang, E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-318 · Cited by 215
Molecular biology of lung cancer: Clinical implications
Fong, K. M., & Minna, J. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00062-5 · Cited by 211
The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non–Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts
Saito, M., Schetter, A. J., Mollerup, S. K., Kohno, T., Skaug, V., Bowman, E. D., Mathé, E. A., Takenoshita, S., Yokota, J., Haugen, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2961 · Cited by 198
MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance
Guan, Y., Mizoguchi, M., Yoshimoto, K., Hata, N., Shono, T., Suzuki, S. O., Araki, Y., Kuga, D., Nakamizo, A., Amano, T., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0207 · Cited by 195
Clinical evaluation of microRNA expression profiling in non small cell lung cancer
Markou, A. N., Sourvinou, I. S., Vorkas, P. A., Yousef, G. M., & Lianidou, E. S. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.05.007 · Cited by 196
Self-citation
Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
Giovannetti, E., Erozenci, L. A., Smit, J., Danesi, R., & Peters, G. J. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.03.010 · Cited by 195
Metastamirs: a stepping stone towards improved cancer management
White, N. M. A., Fatoohi, E., Metias, M., Jung, K., Stephan, C., & Yousef, G. M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.173 · Cited by 184
A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Tan, X., Qin, W., Zhang, L., Hang, J., Li, B., Zhang, C., Wan, J., Zhou, F., Shao, K., Sun, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0419 · Cited by 182
Regulation of cancer metastasis by microRNAs
Chan, S., & Wang, L. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0113-7 · Cited by 179
CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer
Zhu, J., Zeng, Y., Li, W., Qin, H., Lei, Z., Shen, D., Gu, D., Huang, J., & Liu, Z. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0591-1 · Cited by 173
Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia
Abd-El-Fattah, A. A., Sadik, N. A. H., Shaker, O. G., & Aboulftouh, M. L. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9575-y · Cited by 175
Label-free ultrasensitive detection of breast cancer miRNA-21 biomarker employing electrochemical nano-genosensor based on sandwiched AgNPs in PANI and N-doped graphene
Salahandish, R., Ghaffarinejad, A., Omidinia, E., Zargartalebi, H., Majidzadeh‐A, K., Naghib, S. M., & Sanati‐Nezhad, A. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.08.025 · Cited by 165
Adaptive boosting-based computational model for predicting potential miRNA-disease associations
Zhao, Y. F., Chen, X., & Yin, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz297 · Cited by 165
Prognostic significance of serum miRNA‐21 expression in human non‐small cell lung cancer
Wang, Z., Bian, H., Wang, J., Cheng, Z., Wang, K., & De, W. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.22008 · Cited by 159
The roles of miRNAs as potential biomarkers in lung diseases
Alipoor, S. D., Adcock, I. M., Garssen, J., Mortaz, E., Varahram, M., Mirsaeidi, M. S., & Velayati, A. A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.015 · Cited by 159
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
Sotiropoulou, G., Pampalakis, G., Lianidou, E. S., & Mourelatos, Z. (2009) · RNA · doi:10.1261/rna.1534709 · Cited by 158
Self-citation
Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis
Fu, X., Han, Y., Wu, Y., Zhu, X., Lü, X., Mao, F., Wang, X., He, X., Zhao, Y., & Zhao, Y. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02535.x · Cited by 157
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival
Avissar-Whiting, M., McClean, M. D., Kelsey, K. T., & Marsit, C. J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp277 · Cited by 157
Nanoscale Zeolitic Imidazolate Framework-8 for Ratiometric Fluorescence Imaging of MicroRNA in Living Cells
Yi, J., Chen, T., Huo, J., & Chu, X. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03369 · Cited by 154
A simple electrochemical biosensor for highly sensitive and specific detection of microRNA based on mismatched catalytic hairpin assembly
Zhang, Y., Yan, Y., Chen, W., Cheng, W., Li, S., Ding, X., Li, D., Wang, H., Ju, H., & Ding, S. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.01.026 · Cited by 153
Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases
Kulda, V., Pešta, M., Topolčan, O., Liška, V., Třeška, V., Sutnar, A., Rupert, K., Ludvíková, M., Babuška, V., Holubec, L., et al. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.04.015 · Cited by 154
Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker
Zhou, H., Guo, J.-M., Lou, Y., Zhang, X., Zhong, F., Jiang, Z., Cheng, J. R., & Xiao, B. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0617-2 · Cited by 148
MicroRNA-10A* and MicroRNA-21 Modulate Endothelial Progenitor Cell Senescence Via Suppressing High-Mobility Group A2
Zhu, S., Deng, S., Ma, Q., Zhang, T., Jia, C., Zhuo, D., Yang, F., Wei, J., Wang, L., Dykxhoorn, D. M., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.280016 · Cited by 148
MiRNA-21
Gao, W., Lu, X. J., Liu, L., Xu, J., Feng, D., & Shu, Y. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.19073 · Cited by 146
A putative role for microRNA-205 in mammary epithelial cell progenitors
Greene, S. B., Gunaratne, P. H., Hammond, S. M., & Rosen, J. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.056812 · Cited by 145
Upregulation of miR-21 by Ras in vivo and its role in tumor growth
Frezzetti, D., Menna, M. D., Zoppoli, P., Guerra, C. E., Ferraro, A., Bello, A. M., Luca, P. D., Calabrese, C., Fusco, A., Ceccarelli, M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.416 · Cited by 138
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non–Small-Cell Lung Cancer
Rosell, R., Wei, J., & Tarón, M. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.001 · Cited by 133
MiR-205 in cancer: An angel or a devil?
Qin, A.-Y., Zhang, X., Liu, L., Yu, J.-P., Li, H., Wang, S.-Z. E., Ren, X.-B., & Cao, S. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.11.002 · Cited by 130
Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
Wang, J., Raimondo, M., Guha, S., Chen, J., Diao, L., Dong, X., Wallace, M. B., Killary, A. M., Frazier, M. L., Woodward, T. A., et al. (2014) · Journal of Cancer · doi:10.7150/jca.10094 · Cited by 130
Paxillin Predicts Survival and Relapse in Non–Small Cell Lung Cancer by MicroRNA-218 Targeting
Wu, D., Cheng, Y., Wang, J. C. K., Chen, C., & Lee, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2341 · Cited by 127
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
Corsini, L. R., Bronte, G., Terrasi, M., Amodeo, V., Fanale, D., Fiorentino, E., Cicero, G., Bazan, V., & Russo, A. D. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.650632 · Cited by 129
Target-Triggered Enzyme-Free Amplification Strategy for Sensitive Detection of MicroRNA in Tumor Cells and Tissues
Liao, Y., Huang, R. Q., Ma, Z., Wu, Y., Zhou, X., & Xing, D. (2014) · Analytical Chemistry · doi:10.1021/ac5007427 · Cited by 126
MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma
Voortman, J., Goto, A., Mendiboure, J., Sohn, J. J., Schetter, A. J., Saito, M., Dunant, A., Pham, T. C., Petrini, I., Lee, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1348 · Cited by 121
microRNA therapies in cancer
Rothschild, S. I. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-7 · Cited by 120
MicroRNA expression patterns in the bovine mammary gland are affected by stage of lactation
Wang, M., Moisá, S. J., Khan, M. J., Wang, J., Bu, D., & Loor, J. J. (2012) · Journal of Dairy Science · doi:10.3168/jds.2012-5748 · Cited by 115
Intracellular Nonenzymatic In Situ Growth of Three-Dimensional DNA Nanostructures for Imaging Specific Biomolecules in Living Cells
Liu, R., Zhang, S., Zheng, T., Chen, Y.-R., Wu, J., & Wu, Z. (2020) · ACS Nano · doi:10.1021/acsnano.9b09995 · Cited by 113
Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGΒ4-PDCD4) as predictor of metastatic tumor potential
Ferraro, A., Kontos, C. K., Boni, T., Bantounas, I., Siakouli, D., Kosmidou, V., Vlassi, M., Spyridakis, Y., Tsipras, I., Zografos, G., et al. (2014) · Epigenetics · doi:10.4161/epi.26842 · Cited by 111
Breast cancer and microRNAs: therapeutic impact
Iorio, M. V., Casalini, P., Piovan, C., Braccioli, L., & Tagliabue, E. (2011) · The Breast · doi:10.1016/s0960-9776(11)70297-1 · Cited by 111
The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma
Faragalla, H., Youssef, Y. M., Scorilas, A., Khalil, B., White, N. M. A., Mejia‐Guerrero, S., Khella, H. W. Z., Jewett, M. A. S., Evans, A. J., Lichner, Z., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.02.003 · Cited by 113
Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 Regulation
Elgamal, O. A., Park, J. K., Gusev, Y., Azevedo‐Pouly, A. C. P., Jiang, J., Roopra, A., & Schmittgen, T. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076402 · Cited by 110
MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60.
Fix, L. N., Shah, M., Efferth, T., Farwell, M. A., & Zhang, B. (2010) · PubMed · Cited by 110
Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Wang, Q. Z., Xu, W., Habib, N., & Xu, R. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788486731 · Cited by 111
MicroRNA‐137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck
Langevin, S. M., Stone, R. A., Bunker, C. H., Lyons‐Weiler, M. A., LaFramboise, W. A., Kelly, L. A., Seethala, R. R., Grandis, J. R., Sobol, R. W., & Taioli, E. (2010) · Cancer · doi:10.1002/cncr.25689 · Cited by 109
miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3
Li, Z., Cao, Y., Jie, Z., Liu, Y., Li, Y., Li, J., Zhu, G., Liu, Z., Tu, Y., Peng, G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.029 · Cited by 105
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Li, C. H., & Chen, Y. (2015) · Current Genomics · doi:10.2174/1389202916666150707155851 · Cited by 104
MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer
Verdoodt, B., Neid, M., Vogt, M., KUHN, V., Liffers, S., Palisaar, R., Noldus, J., Tannapfel, A., & Mirmohammadsadegh, A. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1915 · Cited by 103
Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells
Peralta-Zaragoza, Ó., Deas, J., Meneses‐Acosta, A., De-la-O-Gómez, F., Fernández‐Tilapa, G., Gómez-Cerón, C., Benítez-Boijseauneau, O., Burguete-García, A. I., Torres-Poveda, K., Bermúdez-Morales, V. H., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2231-3 · Cited by 105
Catalytic Hairpin Assembly Actuated DNA Nanotweezer for Logic Gate Building and Sensitive Enzyme-Free Biosensing of MicroRNAs
Li, D., Cheng, W., Li, Y., Xu, Y., Li, X., Yin, Y., Ju, H., & Ding, S. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04844 · Cited by 102
MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells
Zhang, W., Bai, W., & Zhang, W. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1135-9 · Cited by 101
MicroRNA-21 gene and cancer
Huang, Y., Yang, Y. B., Zhang, X. H., Yu, X. L., Wang, Z. B., & Cheng, X. C. (2012) · Medical Oncology · doi:10.1007/s12032-012-0376-8 · Cited by 102
Regulation of cancer metastasis by cell-free miRNAs
Alečković, M., & Kang, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.005 · Cited by 101
The prognostic importance of miR-21 in stage II colon cancer: a population-based study
Kjær‐Frifeldt, S., Hansen, T. F., Nielsen, B. S., Joergensen, S. L., Lindebjerg, J., Soerensen, F. B., Christensen, R. D., & Jakobsen, A. K. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.365 · Cited by 97
Prognostic Significance of Metastasis-Related MicroRNAs in Early Breast Cancer Patients with a Long Follow-up
Markou, A. N., Yousef, G. M., Stathopoulos, E. N., Georgoulias, V., & Lianidou, E. S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210542 · Cited by 96
Self-citation
MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.
Wong, T., Zhang, X., Zhuang, J. T.-F., Chan, H.-L., Li, C.-H., & Leung, G. (2012) · PubMed · Cited by 94
Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression
Shen, K., Hung, J., Chang, C., Weng, Y., Wu, M., & Chen, P.-S. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.03.005 · Cited by 90
MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas
Hermansen, S. K., Dahlrot, R. H., Nielsen, B. S., Hansen, S., & Kristensen, B. W. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0992-3 · Cited by 89
Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.
Geretto, M., Pulliero, A., Rosano, C., Zhabayeva, D., Bersimbaev, R. I., & Izzotti, A. (2017) · PubMed Central · Cited by 89
Identification of Serum MicroRNA-21 as a Biomarker for Early Detection and Prognosis in Human Epithelial Ovarian Cancer
Xu, Y., Xi, Q., Ge, W., & Zhang, X. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.1057 · Cited by 88

Authors: Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V., & Lianidou, E. S.
Affiliations: National and Kapodistrian University of Athens (GR)
Sotiria General Hospital (GR)
Onassis Cardiac Surgery Center (GR)
University of Crete (GR)
Corresponding author: Lianidou, Evi S
ORCID: Markou, Athina
Georgoulias, Vassilis
Lianidou, Evi S
Venue: Clinical Chemistry
Publisher: Oxford University Press (OUP)
Published: 2008-10-01
Volume: 54
Issue: 10
Pages: 1696-1704
ISSN: 0009-9147 (ISSN-L)
1530-8561
DOI: 10.1373/clinchem.2007.101741
OpenAlex: W2154551754
Cited by: 441
References: 39
Citations by year: 2026: 4 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 21 · 2018: 18 · 2017: 31 · 2016: 26 · 2015: 34 · 2014: 42 · 2013: 33 · 2012: 51
FWCI: 12.41
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
Locations: Clinical Chemistry (publishedVersion)
PubMed (publishedVersion)
Funders: National and Kapodistrian University of Athens
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
Keywords: miR-21, microRNA-205, non-small cell lung cancer, prognostic factors, microRNA overexpression, overall survival, tumor recurrence, microRNA quantification
MeSH terms: Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Prognosis, Multivariate Analysis, Survival Analysis, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks